Hemab Therapeutics Holdings,
COAGOther · NASDAQ · IPO May 1, 2026
01
Company Overview
Hemab Therapeutics Holdings, is filing to list on NASDAQ Global Select. Public information at this stage is limited to the IPO calendar entry; deeper detail typically becomes available closer to pricing via the company's S-1 / prospectus.
Hemab Therapeutics Holdings, is going public on NASDAQ Global Select on 2026-05-01. Offering 16,750,000 shares.
Recent headlines
- Hemab Therapeutics IPO Debut Puts COAG And Pipeline Risks In ...finance.yahoo.com
At a share price of $34.0 and a reported year to date return of 88.9%, NasdaqGS:COAG is entering public markets with some early momentum in its ...
- Hemab Therapeutics Announces Pricing of Upsized Initial Public ...ir.hemab.com
In addition, Hemab has granted the underwriters a 30-day option to purchase up to an additional 2,512,500 shares of common stock at the public ...
- Hemab Therapeutics (NASDAQ: COAG) files IPO to raise $301.5Mstocktitan.net
Hemab Therapeutics is offering 16750000 shares at $18.00 per share, implying $301.5M gross proceeds and Nasdaq listing under COAG.
- Hemab Therapeutics Raises $346.7M in Nasdaq IPO - AllSciallsci.com
Hemab Therapeutics closes $346.7M Nasdaq IPO to fund rare blood disorder therapies. Clinical-stage biotech advances treatment pipeline.
- Hemab Therapeutics (COAG) Prices Upsized IPO at $18 ... - IPOScoopiposcoop.com
Hemab Therapeutics shares jumped to $27.00 – up $9.00 from their $18.00 IPO price for an opening gain of 50 percent – in their NASDAQ debut.
02
AI Analysis
Possible growth narrative
Sits adjacent to Other — themes that are currently drawing meaningful capital and attention.
Risks
Newly public companies typically face limited operating history disclosure, lock-up expirations, and broader market sentiment swings around IPOs.
Volatility
Expect elevated price volatility in the first weeks of trading as supply and demand find balance.
Market attention
Recently listed — monitoring early trading activity and analyst initiations.
Educational summary only. Not investment advice.
03
Related Themes
04
IPO Information
- IPO date
- May 1, 2026
- Exchange
- NASDAQ
- Status
- Recently Listed
- Industry
- Other
- Valuation
- $301.5M raise
- Headquarters
- —
- Attention score
- 61 / 100
- Ticker
- COAG